-+ 0.00%
-+ 0.00%
-+ 0.00%
DNA X delays quarterly filing over preferred stock accounting
Share
Listen to the news
DNA X delays quarterly filing over preferred stock accounting
  • DNA X delayed its Form 10-Q for the three months ended September 30, 2026, as preferred stock accounting prolonged its financial close.
  • The accounting review concerns related-party preferred stock issuances, including whether to classify the stock as mezzanine equity or permanent equity.
  • The company expects to file within five calendar days of the prescribed due date.
  • Net loss from continuing operations is expected at approximately $1.3 million, versus approximately $2.2 million in the corresponding 2025 period.
  • The narrower loss reflects $500,000 in prior-year interest expense on promissory notes repaid in January 2026 and $400,000 in prior-year divestiture-related legal fees.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-052817), on November 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending